These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35204712)

  • 1. Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.
    Malik V; Radhakrishnan N; Kaul SC; Wadhwa R; Sundar D
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
    Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
    PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells.
    Kumar V; Dhanjal JK; Bhargava P; Kaul A; Wang J; Zhang H; Kaul SC; Wadhwa R; Sundar D
    J Biomol Struct Dyn; 2022 Jan; 40(1):1-13. PubMed ID: 32469279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
    Purushotham PM; Kim JM; Jo EK; Senthil K
    Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers.
    Malik V; Kumar V; Kaul SC; Wadhwa R; Sundar D
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
    Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
    PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts.
    Kaul SC; Ishida Y; Tamura K; Wada T; Iitsuka T; Garg S; Kim M; Gao R; Nakai S; Okamoto Y; Terao K; Wadhwa R
    PLoS One; 2016; 11(12):e0166945. PubMed ID: 27936030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences.
    Chaudhary A; Kalra RS; Malik V; Katiyar SP; Sundar D; Kaul SC; Wadhwa R
    Sci Rep; 2019 Nov; 9(1):17344. PubMed ID: 31757995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors.
    Singh VK; Chang HH; Kuo CC; Shiao HY; Hsieh HP; Coumar MS
    J Biomol Struct Dyn; 2017 Jun; 35(8):1833-1848. PubMed ID: 27353341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M
    Kumar V; Dhanjal JK; Kaul SC; Wadhwa R; Sundar D
    J Biomol Struct Dyn; 2021 Jul; 39(11):3842-3854. PubMed ID: 32431217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.
    Wang J; Zhang H; Kaul A; Li K; Priyandoko D; Kaul SC; Wadhwa R
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680087
    [No Abstract]   [Full Text] [Related]  

  • 12. Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera.
    Grover A; Katiyar SP; Jeyakanthan J; Dubey VK; Sundar D
    BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S20. PubMed ID: 23281834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis,
    Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
    Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.
    Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M
    Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
    Vadloori B; Sharath AK; Prabhu NP; Maurya R
    BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jahagirdar S; Praveen Kumar H; Bhat SS; Poddar A; Chattaraj PK; Ahmad SF; Prasad SK
    Hum Exp Toxicol; 2024; 43():9603271241291399. PubMed ID: 39397382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
    Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
    J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia.
    Roskoski R
    Pharmacol Res; 2022 Apr; 178():106156. PubMed ID: 35257901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
    Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
    Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells.
    Wang XY; Sun GB; Wang YJ; Yan F
    Biol Pharm Bull; 2020; 43(10):1526-1533. PubMed ID: 32999163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.